Here we aimed at investigating in greater details the THK5117 binding using large frozen sections from autopsied AD brains, and compared its binding pattern with measured tau histopathology as well as with previous in vivo measurement of 18F-FDG PET imaging in the same patients. The gene discussed is MAPT; the disease is Alzheimer disease.